

| Catalog No. | JN886014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Description |
Anti-Streptococcus pyogenes speB/Streptopain Polyclonal Antibody (JN886014) is a rabbit polyclonal antibody detecting Streptopain in ELISA, IHC, WB.
Highlights
|
||||||||
| Species reactivity | Streptococcus pyogenes, Streptococcus pyogenes serotype M1, Streptococcus pyogenes serotype M18, Streptococcus pyogenes serotype M28, Streptococcus pyogenes serotype M3, Streptococcus pyogenes serotype M6 | ||||||||
| Applications | ELISA, IHC, WB | ||||||||
| Host species | Rabbit | ||||||||
| Isotype | IgG | ||||||||
| Clonality | Polyclonal | ||||||||
| Immunogen | E. coli - derived recombinant Streptococcus pyogenes speB/Streptopain (Gln146-Pro398). | ||||||||
| Target | Streptopain, 3.4.22.10, Exotoxin type B, SPE B, Streptococcal cysteine proteinase, Streptococcus peptidase A, SPP, speB | ||||||||
| Purification | Purified by antigen affinity column. | ||||||||
| Accession | P0C0J0 | ||||||||
| RRID | Anti-Streptococcus pyogenes speB/Streptopain Polyclonal Antibody (abinScience Cat# JN886014, RRID:AB_3730592) |
||||||||
| Form | Liquid | ||||||||
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||||||
| Product Usage Information |
| ||||||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||||||
| Background | Streptopain (speB) is a ~43 kDa protein. Cysteine protease that acts as a key streptococcal virulence factor by cleaving host proteins involved in immune response. Triggers inflammation by mediating cleavage of host proteins, which can both promote host pathogenesis by triggering sterile inflammation and/or restrict streptococcal infection, depending on host immune statue and infection site. Cleaves host gasdermin-A (GSDMA) in epithelial cells, promoting GSDMA activation and formation of gasdermin pores, triggering pyroptosis. Pyroptosis triggers the elimination of the infected skin cell, depriving the pathogen of its protective niche, while inducing an inflammatory response. This ultimately prevents bacterial penetration of the epithelial barrier and a subsequent systemic dissemination of the pathogen. 1. Doran, JD. et al. (1999) European journal of biochemistry 263, 145-51. PMID: 10429198 2. Nomizu, M. et al. (2001) The Journal of biological chemistry 276, 44551-6. PMID: 11553627 3. Yu, CE. et al. (1991) Infection and immunity 59, 211-5. PMID: 1987034 4. González-Páez, GE. et al. (2012) The Journal of biological chemistry 287, 24412-26. PMID: 22645124 5. Musser, JM. et al. (1996) Infection and immunity 64, 1913-7. PMID: 8675287 6. Lukomski, S. et al. (1997) The Journal of clinical investigation 99, 2574-80. PMID: 9169486 7. Kuo, CF. et al. (1999) Infection and immunity 67, 126-30. PMID: 9864206 8. Kapur, V. et al. (1993) Proceedings of the National Academy of Sciences of the United States of America 90, 7676-80. PMID: 7689226 9. Kapur, V. et al. (1993) Microbial pathogenesis 15, 327-46. PMID: 7516997 | ||||||||
| Note | For research use only. |

Western blot analysis was performed using anti-Streptococcus pyogenes speB/Streptopain polyclonal antibody at 1ug/mL on recombinant Streptococcus pyogenes speB/Streptopain (Catalog No. JN886012).


Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский